Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3582)
All Articles published online
|
Jul 14, 2006 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4185.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
D. Tougeron, M. Scotté, H. Hamidou, F. Di Fiore, B. Paillot, F. Michot, P. Michel. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?. Journal of Surgical Oncology 2012; 105(8): 761 doi: 10.1002/jso.22157
|
| 3 |
Andrew Youssef, Carrie Lavergne, Mark Niglas, Deanna N. G.Humphreys, Abrielle Fulton, Ayesha Fathima, Youssef Youssef. The Association of Change in Weight During Radiotherapy Treatment With Clinical Outcomes in Patients With Stage I–III Esophageal Cancer. Nutrition and Cancer 2024; 76(4): 356 doi: 10.1080/01635581.2024.2316935
|
| 4 |
Ankit Bharat, Traves Crabtree. Management of Advanced-Stage Operable Esophageal Cancer. Surgical Clinics of North America 2012; 92(5): 1179 doi: 10.1016/j.suc.2012.07.012
|
| 5 |
Hae Jin Shin, Hee Seok Moon, Sun Hyung Kang, Jae Kyu Sung, Hyun Yong Jeong, Seok Hyun Kim, Byung Seok Lee, Ju Seok Kim, Gee Young Yun. Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma. Medicine 2017; 96(51): e9441 doi: 10.1097/MD.0000000000009441
|
| 6 |
Minghuan Li, Xiaoli Zhang, Fen Zhao, Yijun Luo, Li Kong, Jinming Yu. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiation Oncology 2016; 11(1) doi: 10.1186/s13014-016-0589-7
|
| 7 |
Yuki Wada, Akira Anbai, Noriko Takagi, Satoshi Kumagai, Eriko Okuyama, Hiroshi Nanjo, Yusuke Sato, Satoru Motoyama, Manabu Hashimoto. Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study. Cancers 2020; 13(1): 8 doi: 10.3390/cancers13010008
|
| 8 |
D. Tougeron, J.-P. Richer, C. Silvain. Management of esophageal adenocarcinoma. Journal of Visceral Surgery 2011; 148(3): e161 doi: 10.1016/j.jviscsurg.2011.05.008
|
| 9 |
Xiao-Li Yu, Jin Yang, Ting Chen, Yi-min Liu, Wei-ping Xue, Ming-Hui Wang, Shou-Min Bai. Excessive Pretreatment Weight Loss Is a Risk Factor for the Survival Outcome of Esophageal Carcinoma Patients Undergoing Radical Surgery and Postoperative Adjuvant Chemotherapy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6075207
|
| 10 |
I-Ying Kuo, Yu-Lin Huang, Chien-Yu Lin, Chien-Hsun Lin, Wei-Lun Chang, Wu-Wei Lai, Yi-Ching Wang. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes. Journal of Biomedical Science 2019; 26(1) doi: 10.1186/s12929-019-0510-4
|
| 11 |
Zhen-Bin Ma, Guang-Hong Guo, Qiong Niu, Ning Shi. Role of EZH2 Polymorphisms in Esophageal Squamous Cell Carcinoma Risk in Han Chinese Population. International Journal of Molecular Sciences 2014; 15(7): 12688 doi: 10.3390/ijms150712688
|
| 12 |
Dong-Churl Suh, Christopher A. Powers, Joseph A. Barone, HyunChul Shin, Jinweon Kwon, Susan Goodin. Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: A microcosting study. Research in Social and Administrative Pharmacy 2010; 6(3): 246 doi: 10.1016/j.sapharm.2009.07.004
|
| 13 |
V. Prevost, C. Joubert, N. Heutte, E. Babin. Évaluation du statut nutritionnel et qualité de vie en cancérologie ORL. Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale 2014; 131(2): 99 doi: 10.1016/j.aforl.2014.02.011
|
| 14 |
Hirotake Saito, Atsushi Ohta, Eisuke Abe, Motoki Kaidu, Miki Shioi, Toshimichi Nakano, Tomoya Oshikane, Kensuke Tanaka, Katsuya Maruyama, Naotaka Kushima, Satoshi Tanabe, Satoru Utsunomiya, Ryuta Sasamoto, Hidefumi Aoyama. Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. Clinical and Translational Radiation Oncology 2018; 9: 12 doi: 10.1016/j.ctro.2017.12.003
|
| 15 |
Emilie Ferrat, Etienne Audureau, Elena Paillaud, Evelyne Liuu, Christophe Tournigand, Jean-Leon Lagrange, Florence Canoui-Poitrine, Philippe Caillet, Sylvie Bastuji-Garin. Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2016; 71(12): 1653 doi: 10.1093/gerona/glw052
|
| 16 |
X.-F. Cao, X.-T. He, L. Ji, J. Xiao, J. Lv. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Diseases of the Esophagus 2009; 22(6): 477 doi: 10.1111/j.1442-2050.2008.00910.x
|
| 17 |
Dae-Eun Kim, Uh-Jin Kim, Won-Young Choi, Mi-Young Kim, Seung-Hun Kim, Min-Jee Kim, Hyun-Jeong Shim, Jun-Eul Hwang, Woo-Kyun Bae, Ik-Joo Chung, Taek-Keun Nam, Kook-Joo Na, Sang-Hee Cho. Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy. Cancer Research and Treatment 2013; 45(4): 276 doi: 10.4143/crt.2013.45.4.276
|
| 18 |
Emilie Ferrat, Elena Paillaud, Marie Laurent, Aurélie Le Thuaut, Philippe Caillet, Christophe Tournigand, Jean-Léon Lagrange, Florence Canouï-Poitrine, Sylvie Bastuji-Garin. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2015; 70(9): 1148 doi: 10.1093/gerona/glv025
|
| 19 |
D. Tougeron, J.-P. Richer, C. Silvain. Traitement des adénocarcinomes de l’œsophage. Journal de Chirurgie Viscérale 2011; 148(3): 184 doi: 10.1016/j.jchirv.2011.03.011
|
| 20 |
Zhenhuan Zhao, Yixue Wen, Dongbiao Liao, Jidong Miao, Yan Gui, Hongwei Cai, Yang Chen, Min Wei, Qiang Jia, Honggang Tian, Mingqiang Sun, Yu Zhang, Gang Feng, Xiaobo Du. Single-Agent Versus Double-Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial. The Oncologist 2020; 25(12): e1900 doi: 10.1634/theoncologist.2020-0808
|
| 21 |
Jacqueline Bauer, Heribert Jürgens, Michael C. Frühwald. Important Aspects of Nutrition in Children with Cancer. Advances in Nutrition 2011; 2(2): 67 doi: 10.3945/an.110.000141
|
| 22 |
HAIPING YANG, LIJUAN XU, HAILI QIAN, XINQIANG NIU, DAN ZHAO, ZHILONG ZHAO, JUN WU, JUNFENG LIU, YANYU WANG. Correlation between insulin-like growth factor binding protein 3 and metastasis-associated gene 1 protein in esophageal squamous cell carcinoma. Molecular Medicine Reports 2016; 13(5): 4143 doi: 10.3892/mmr.2016.5046
|
| 23 |
D Tougeron, F Di Fiore, S Thureau, N Berbera, I Iwanicki-Caron, H Hamidou, B Paillot, P Michel. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. British Journal of Cancer 2008; 99(10): 1586 doi: 10.1038/sj.bjc.6604749
|
| 24 |
V. Prevost, C. Joubert, N. Heutte, E. Babin. Assessment of nutritional status and quality of life in patients treated for head and neck cancer. European Annals of Otorhinolaryngology, Head and Neck Diseases 2014; 131(2): 113 doi: 10.1016/j.anorl.2013.06.007
|
| 25 |
J. Skipworth, J. Foster, D. Raptis, F. Hughes. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Diseases of the Esophagus 2009; 22(7): 559 doi: 10.1111/j.1442-2050.2009.00939.x
|
| 26 |
Pavel Vítek, Jiří Kubeš. What are the benefits of proton beam therapy for esophageal cancer?. Onkologie 2022; 16(5): 239 doi: 10.36290/xon.2022.045
|
| 27 |
Stéphane Lecleire, Frédéric Di Fiore, Michel Antonietti, Emmanuel Ben-Soussan, Patrick Hochain, Eric Lerebours, Pierre Michel, Philippe Ducrotté. Nonoperable Patients With Superficial Esophageal Cancer Treated by Photodynamic Therapy After Chemoradiotherapy Have More Severe Complications Than Patients Treated in Primary Intent. The American Journal of Gastroenterology 2008; 103(9): 2215 doi: 10.1111/j.1572-0241.2008.02042.x
|
| 28 |
Sonia A. Duffy, David L. Ronis, Scott McLean, Karen E. Fowler, Stephen B. Gruber, Gregory T. Wolf, Jeffrey E. Terrell. Pretreatment Health Behaviors Predict Survival Among Patients With Head and Neck Squamous Cell Carcinoma. Journal of Clinical Oncology 2009; 27(12): 1969 doi: 10.1200/JCO.2008.18.2188
|
| 29 |
A. Duclos, F. Di Fiore, S. Lecleire, P. Michel. Predictive and prognostic factors in patients with an oesophageal carcinoma treated with chemoradiotherapy: The key role of nutritional parameters. Gastroentérologie Clinique et Biologique 2009; 33(6-7): 491 doi: 10.1016/j.gcb.2009.02.041
|
| 30 |
Lei Zhao, Li-Ru He, Rui Zhang, Mu-Yan Cai, Yi-Ji Liao, Dong Qian, Mian Xi, Yi-Xin Zeng, Dan Xie, Meng-Zhong Liu. Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medical Oncology 2012; 29(4): 2669 doi: 10.1007/s12032-011-0133-4
|
| 31 |
M. Hurmuzlu, O. R. Monge, R. Smaaland, A. Viste. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome. Diseases of the Esophagus 2010; 23(3): 244 doi: 10.1111/j.1442-2050.2009.00999.x
|
| 32 |
Hamid Yimam Hassen, Mohammed Ahmed Teka, Adamu Addisse. Survival Status of Esophageal Cancer Patients and its Determinants in Ethiopia: A Facility Based Retrospective Cohort Study. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.594342
|
| 33 |
P. Michel, I. Iwanicki-Caron, F. Di Fiore. Thérapeutique du cancer. 2011; : 327 doi: 10.1007/978-2-8178-0021-9_21
|
| 34 |
Tyler R. Grenda, Andrew C. Chang. Difficult Decisions in Thoracic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach 2014; 1: 301 doi: 10.1007/978-1-4471-6404-3_24
|
| 35 |
Guillaume Piessen, Mathieu Messager, Xavier Mirabel, Nicolas Briez, William B. Robb, Antoine Adenis, Christophe Mariette. Is There a Role for Surgery for Patients with a Complete Clinical Response after Chemoradiation for Esophageal Cancer? An Intention-to-Treat Case-Control Study. Annals of Surgery 2013; 258(5): 793 doi: 10.1097/SLA.0000000000000228
|
| 36 |
Lei Zhao, Feng Chi, Mian Xi, Jing-Xian Shen, Qiao-Qiao Li, Li-Ru He, Shi-Liang Liu, Meng-Zhong Liu. Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2015; 74: 148 doi: 10.1016/j.biopha.2015.08.021
|
| 37 |
A.A. Aaldriks, E. Maartense, S. le Cessie, E.J. Giltay, H.A.C.M. Verlaan, L.G.M. van der Geest, W.M. Kloosterman-Boele, M.T. Peters-Dijkshoorn, B.A. Blansjaar, H.W. van Schaick, J.W.R. Nortier. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Critical Reviews in Oncology/Hematology 2011; 79(2): 205 doi: 10.1016/j.critrevonc.2010.05.009
|
| 38 |
Guillaume Piessen, Nicolas Briez, Jean-Pierre Triboulet, Christophe Mariette. Patients with Locally Advanced Esophageal Carcinoma Nonresponder to Radiochemotherapy: Who Will Benefit From Surgery?. Annals of Surgical Oncology 2007; 14(7): 2036 doi: 10.1245/s10434-007-9405-9
|
| 39 |
Seok Yun Kang, Jae Ho Han, Kwang Jae Lee, Jin-Hyuk Choi, Jung Il Park, Hyoung Il Kim, Hyun-Woo Lee, Jun Ho Jang, Joon Seong Park, Hugh Chul Kim, Seunghee Kang, Young Taek Oh, Mison Chun, Jang Hee Kim, Seung Soo Sheen, Ho-Yeong Lim. Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive Chemoradiotherapy. Clinical Cancer Research 2007; 13(14): 4146 doi: 10.1158/1078-0432.CCR-06-3063
|
| 40 |
Martine Extermann, Arti Hurria. Comprehensive Geriatric Assessment for Older Patients With Cancer. Journal of Clinical Oncology 2007; 25(14): 1824 doi: 10.1200/JCO.2007.10.6559
|
| 41 |
S. Lecleire, M. Antonietti, I. Iwanicki-Caron, A. Duclos, F. Lemoine, F. L. Pessot, P. Michel, P. Ducrotté, F. Di Fiore. Lugol chromo-endoscopy versus Narrow Band Imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study. Diseases of the Esophagus 2011; 24(6): 418 doi: 10.1111/j.1442-2050.2010.01164.x
|
| 42 |
Wei-Lun Chang, Wu-Wei Lai, I-Ying Kuo, Chien-Yu Lin, Pei-Jung Lu, Bor-Shyang Sheu, Yi-Ching Wang. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. Journal of Gastroenterology 2017; 52(6): 705 doi: 10.1007/s00535-016-1265-2
|
| 43 |
Jin Lü, Xiufeng Cao, Bin Zhu, Lü Ji. A prospective study: intraoperative 125I radioactive seed implant therapy in advanced esophageal squamous cell carcinoma. Journal of Nanjing Medical University 2009; 23(5): 335 doi: 10.1016/S1007-4376(09)60080-0
|
| 44 |
HONG-YU XU, ZE-DONG DU, LIN ZHOU, MIN YU, ZHEN-YU DING, YOU LU. Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma. Oncology Letters 2014; 7(1): 260 doi: 10.3892/ol.2013.1694
|
| 45 |
Yusuke Uchinami, Miyako Myojin, Hiroaki Takahashi, Keiichi Harada, Shinichi Shimizu, Masao Hosokawa. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa. Radiation Oncology 2016; 11(1) doi: 10.1186/s13014-016-0660-4
|
| 46 |
Yuanwei Huang, Haidong Wang, Ganfeng Luo, Yanting Zhang, Li Wang, Ke Li. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma. International Journal of Surgery 2017; 38: 41 doi: 10.1016/j.ijsu.2016.12.035
|
| 47 |
Williams Tessier, Guillaume Piessen, Nicolas Briez, Arianna Boschetto, Géraldine Sergent, Christophe Mariette. Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy. Surgical Endoscopy 2013; 27(2): 633 doi: 10.1007/s00464-012-2506-y
|
| 48 |
Frédéric Di Fiore, Stéphane Lecleire, Daniela Pop, Olivier Rigal, Hadji Hamidou, Bernard Paillot, Philippe Ducrotté, Eric Lerebours, Pierre Michel. Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer. The American Journal of Gastroenterology 2007; 102(11): 2557 doi: 10.1111/j.1572-0241.2007.01437.x
|
| 49 |
Li‐Ru He, Meng‐Zhong Liu, Bin‐Kui Li, Hui‐Lan Rao, Hai‐Xia Deng, Xin‐Yuan Guan, Yi‐Xin Zeng, Dan Xie. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. Cancer Science 2009; 100(9): 1591 doi: 10.1111/j.1349-7006.2009.01224.x
|
| 50 |
Su Youn Nam, Seong Woo Jeon, Sang Jik Lee, Yong Hwan Kwon, Hyun Seok Lee, Sung Kook Kim. Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients. Gut and Liver 2020; 14(4): 450 doi: 10.5009/gnl19165
|